Differential effect on serum neopterin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia
- PMID: 8169417
- DOI: 10.1093/infdis/169.5.1170
Differential effect on serum neopterin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia
Abstract
Forty-three human immunodeficiency virus-infected patients with Pneumocystis carinii pneumonia (PCP) were enrolled in a study of adjunctive corticosteroid treatment for 10 days versus placebo, in addition to antimicrobial treatment. Levels of neopterin and beta 2-microglobulin (beta 2M) were determined in consecutive serum samples. Initiation of antimicrobial treatment resulted in significantly increased neopterin levels, whereas beta 2M levels slightly decreased from pretreatment levels. In patients treated with corticosteroid, both neopterin and beta 2M decreased, by approximately 50% and approximately 30%, respectively, and returned to baseline after discontinuation of corticosteroid treatment. Antimicrobial treatment alone did not affect either neopterin or beta 2M in healthy controls. Results indicate that treatment has a differential effect on the immune response: increased macrophage activation leading to neopterin production and decreased production of beta 2M by lymphocytes. Further, addition of corticosteroids modified and decreased this immune activation and may explain the earlier demonstrated beneficial effect of corticosteroids in PCP treatment.
Similar articles
-
Changes in serum neopterin and serum beta 2-microglobulin in subjects with lung infections.Eur Respir J. 1994 Jul;7(7):1233-8. doi: 10.1183/09031936.94.07071233. Eur Respir J. 1994. PMID: 7925900
-
The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.J Acquir Immune Defic Syndr (1988). 1992;5(3):215-21. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1346807 Clinical Trial.
-
Factors influencing serum neopterin and beta 2-microglobulin levels in a healthy diverse population.J Clin Immunol. 1994 Nov;14(6):368-74. doi: 10.1007/BF01546321. J Clin Immunol. 1994. PMID: 7883864
-
[Acquired immunodeficiency syndrome (AIDS). A 2-year review].Dtsch Med Wochenschr. 1983 Dec 16;108(50):1927-33. doi: 10.1055/s-2008-1069853. Dtsch Med Wochenschr. 1983. PMID: 6228417 Review. German. No abstract available.
-
[Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].Enferm Infecc Microbiol Clin. 1998;16 Suppl 1:36-44. Enferm Infecc Microbiol Clin. 1998. PMID: 9859618 Review. Spanish.
Cited by
-
Immunological features of Pneumocystis carinii infection in humans.Clin Diagn Lab Immunol. 1999 Mar;6(2):149-55. doi: 10.1128/CDLI.6.2.149-155.1999. Clin Diagn Lab Immunol. 1999. PMID: 10066645 Free PMC article. Review. No abstract available.
-
Sensitized splenocytes result in deleterious cytokine cascade and hyperinflammatory response in rats with Pneumocystis pneumonia despite the presence of corticosteroids.Infect Immun. 2004 Feb;72(2):757-65. doi: 10.1128/IAI.72.2.757-765.2004. Infect Immun. 2004. PMID: 14742518 Free PMC article.
-
The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes.Infect Immun. 1997 Nov;65(11):4790-4. doi: 10.1128/iai.65.11.4790-4794.1997. Infect Immun. 1997. PMID: 9353066 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials